Products
AI Benchmark
Monthly visits
100.4K
Up181.1%MoMOct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
Usage-based
No monthly subscription pricing
Creators
omniakey.com
@omniakey2026· 0 followers
Launched
32d ago
2026-10-13 · Est.

Traffic

Last 12 months
Monthly visitsData through Oct 2026
Events1 marketing move

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on DevHunt (1 upvotes · 1 comments)Launch

    OmniaKey — An LLM gateway for coding agents.

    Oct 13 · 32d agoLaunch page

    At the time: 35.7K visits/moVisits: prior 1 mo +125%, next 1 mo +181%

Open Source & Agent Ecosystem

GitHub · MCP / Skill
GitHub Stars
Public repo
Forks
—
License
See repository
Primary language
—

Agent, MCP & Developer Integration

MCP ServerCLI / SDKAPI
Integration docs
Browse all MCP Server products →

Traffic sources

Oct 2026

Traffic breakdown

Channels

  • Organic Search54%
  • Direct32%
  • Referrals8%
  • Other5%

Countries

  • China25%
  • Germany9%
  • United States8%
  • South Korea6%
  • Indonesia5%

Search

Domain authority —Domain registered 2026-02-27

KeywordMonthly volume
opus 5.5628.2K
fable 5.5517.6K
sonnet 5.5179.4K
fable 5.5 release date43.7K
omniakey200

Traffic data: Vaneform

Pricing

Public pricing: One time feeRaw source text; structured plans are extracted after website capture.

Pages & changes

Tracked since 2026-11-10

Key pages

Weekly snapshots

No page snapshots yet. Once followed, home and pricing pages are captured weekly.

    Changes

    No pricing, plan, or positioning changes detected since tracking started.

    Questions & evidence

    How much website traffic does OmniaKey get?
    Vaneform estimates 100.4K website visits in 2026-10. Visits can include repeat visits; this estimate does not measure paying customers or revenue.Source

    Related products in this category

    AI Models & Agents / Model APIs & Gateways

    These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.